share_log

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-10% Owner LILLY ENDOWMENT INC

SEC announcement ·  Feb 17 05:09
Summary by Futu AI
On February 15, 2024, Lilly Endowment Inc completed a sale of Eli Lilly and Co (LLY) common stock. The transactions were executed in the open market, with a total of 50,316 shares sold. The sales occurred at prices ranging from $760.191 to $762.261 per share, resulting in a total market value of approximately $38.26 million. Following these transactions, Lilly Endowment Inc's direct holdings in Eli Lilly and Co amounted to 99,068,494 shares of common stock.
On February 15, 2024, Lilly Endowment Inc completed a sale of Eli Lilly and Co (LLY) common stock. The transactions were executed in the open market, with a total of 50,316 shares sold. The sales occurred at prices ranging from $760.191 to $762.261 per share, resulting in a total market value of approximately $38.26 million. Following these transactions, Lilly Endowment Inc's direct holdings in Eli Lilly and Co amounted to 99,068,494 shares of common stock.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.